DAIRY PRIDE Act
Sponsored By: Representative Joyce (PA)
Introduced
Summary
Prevents non-dairy products from using standardized dairy names unless they truly meet a dairy definition or the law's imitation rules. This bill would add a new misbranding rule to the Federal Food, Drug, and Cosmetic Act that makes using a dairy name unlawful unless the product meets a specified dairy definition and the statute's imitation requirements.
Show full summary
- Consumers: Clearer naming for foods that use dairy terms so shoppers can better tell true dairy from imitations.
- Food makers: Companies that use names tied to standardized dairy products would need to use actual dairy as the primary ingredient or stop using those names.
- Regulators: The Department of Health and Human Services, through the FDA, must issue draft guidance within 90 days and final guidance within 180 days.
- Congress reporting: The Secretary must report to Congress within two years on warnings, penalties, and any updated enforcement plan if misbranded foods remain in interstate commerce.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
New rules on dairy product names
If enacted, the bill would make it unlawful to sell across state lines a food that uses a standardized dairy product name unless the product is made from milk or is labeled as an imitation. The bill would define a dairy product as a food made from, containing as the main ingredient, or derived from the milk of hooved mammals and practically free of colostrum. Protected dairy names would come from specific FDA standards of identity in 21 C.F.R. parts 131 and 133, certain 135 rules, or any other term with a federal standard of identity. The FDA would have to issue draft guidance within 90 days and final guidance within 180 days after enactment. Any prior FDA guidance that conflicts would no longer have effect on the date of enactment, and the FDA must report to Congress within 2 years about warnings, penalties, and an updated enforcement plan if mislabeled products are still sold.
Sponsors & CoSponsors
Sponsor
Joyce (PA)
PA • R
Cosponsors
Riley (NY)
NY • D
Sponsored 4/21/2026
Rep. Thompson, Glenn [R-PA-15]
PA • R
Sponsored 4/22/2026
Simpson
ID • R
Sponsored 4/27/2026
Rep. Finstad, Brad [R-MN-1]
MN • R
Sponsored 4/28/2026
Rep. Tenney, Claudia [R-NY-24]
NY • R
Sponsored 4/28/2026
Wied
WI • R
Sponsored 4/30/2026
Rep. Steil, Bryan [R-WI-1]
WI • R
Sponsored 5/11/2026
Fitzgerald
WI • R
Sponsored 5/13/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov